Device Heart Valves

Freestyle

Payments companies reported to CMS as associated with Freestyle. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$13Kassociated payments (2023-2025)
133clinicians with associated payments
1company reporting

By year

2023 $7,484
2024 $719
2025 $5,215

Payments reported as associated with Freestyle, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $9,196
Anesthesiology $766
Surgery $601
Surgical $392
Physician Assistant $367
Critical Care Medicine (Anesthesiology) $294

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Freestyle

These are the largest totals companies reported as associated with Freestyle. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Neal Kon Winston Salem, NC Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,878.99
Tom Theruvath Charlotte, NC Thoracic Surgery (Cardiothoracic Vascular Surgery) $423.84
Yasir Abu-Omar Cleveland, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $261.65
Joseph Sabik Cleveland, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $261.64
Joseph Rubelowsky Raleigh, NC Thoracic Surgery (Cardiothoracic Vascular Surgery) $261.64
Yakov Elgudin Cleveland, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $261.64
Alan Markowitz Cleveland, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $212.67
Taras Lysyy Saint Louis, MO Thoracic Surgery (Cardiothoracic Vascular Surgery) $206.81
Charles Levesque Mesa, AZ Surgical $202.27
Louis Brunsting Cincinnati, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $194.41

Prescribed Freestyle?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.